Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples